EUVIMEDEUVIMED entdecken
LeitlinieStudienprotokollOpen Access · CC BY 4.0

Protocol for the Development of The Australian Motor Neurone Disease (MND) Guideline

Cindy Stern iD, Danielle Pollock iD, Timothy Barker iD, Grace McKenzie Holland iD, Sabira Hasanoff iD, Nipun Shrestha iD, Ines Semendric iD, Lemma Negesa Bulto iD, Sitasma Sharma iD, Anna Fragkoudi iD, Sebastian Cole Facchin-Young iD, Abigail Molly Day-Sharman iD und 8 weitere

Clinical and Public Health Guidelines · 2026-01 · 3 (1)

DOI: 10.1002/gin2.70055 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical and Public Health Guidelines, online erschienen am 10.12.2025. Verfasst von Cindy Stern und 19 weiteren Autor:innen. Beteiligte Einrichtung: Health Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adel…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Motor neurone disease (MND) is a rare but devastating neurodegenerative condition that results in progressive muscle weakness, disability, and eventual respiratory failure. In Australia, the impact of MND is significant, and there is a pressing need for a high‐quality, locally relevant guideline to support equitable, person‐centred care. Questions This guideline aims to address key clinical and care‐related questions that arise across the MND trajectory. It will identify the most pressing topics and uncertainties in MND management through interest holder consultation and structured prioritisation.

Methods

The guideline will be developed using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach and will align with standards set by the National Health and Medical Research Council (NHMRC) and the Guidelines International Network (GIN). Governance will include a multi‐tiered structure with lived experience representation. Implementation planning and evaluation will be integrated throughout, with a planned transition to a living guideline model supported by an ongoing evidence surveillance strategy.

Schlagwörter

Stichwörter der Autor:innen

GRADELou Gehrig's diseaseamyotrophic lateral sclerosisguidelinelived experience, care management, implementationmotor neurone diseaseneurodegenerative diseases

Autor:innen und Institutionen

  • Health Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.
  • School of Biomedicine, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.
  • University Library The University of Adelaide Adelaide Australia.
  • Adelaide Health Technology Assessment (AHTA), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.
  • School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.
  • Brain and Nerve Research Centre, Concord Clinical School The University of Sydney Sydney Australia.

ORCID-Profile: Cindy Stern, Danielle Pollock, Timothy Barker, Grace McKenzie Holland, Sabira Hasanoff, Nipun Shrestha, Ines Semendric, Lemma Negesa Bulto, Sitasma Sharma, Anna Fragkoudi, Sebastian Cole Facchin-Young, Abigail Molly Day-Sharman, Lara Stollery, Jay Beasley-Hall, Camille Schubert, Lynne Giles, Tracy Merlin, Zachary Munn

Zitieren

APA

Stern, C., Pollock, D., Barker, T., Holland, G. M., Hasanoff, S., Shrestha, N., Semendric, I., Bulto, L. N., Sharma, S., Fragkoudi, A., Facchin-Young, S. C., Day-Sharman, A. M., Stollery, L., Beasley-Hall, J., Schubert, C., Giles, L., Merlin, T., Vucic, S., Whitehouse, J., & Munn, Z. (2026). Protocol for the Development of The Australian Motor Neurone Disease (MND) Guideline. Clinical and Public Health Guidelines, 3(1). https://doi.org/10.1002/gin2.70055

Vancouver

Stern C, Pollock D, Barker T, Holland GM, Hasanoff S, Shrestha N, et al. Protocol for the Development of The Australian Motor Neurone Disease (MND) Guideline. Clinical and Public Health Guidelines. 2026;3(1). doi:10.1002/gin2.70055

BibTeX
@article{Stern2026,
  author = {Stern, Cindy and Pollock, Danielle and Barker, Timothy and Holland, Grace McKenzie and Hasanoff, Sabira and Shrestha, Nipun and Semendric, Ines and Bulto, Lemma Negesa and Sharma, Sitasma and Fragkoudi, Anna and Facchin-Young, Sebastian Cole and Day-Sharman, Abigail Molly and Stollery, Lara and Beasley-Hall, Jay and Schubert, Camille and Giles, Lynne and Merlin, Tracy and Vucic, Steve and Whitehouse, Jo and Munn, Zachary},
  title = {Protocol for the Development of The Australian Motor Neurone Disease (MND) Guideline},
  journal = {Clinical and Public Health Guidelines},
  year = {2026},
  volume = {3},
  number = {1},
  doi = {10.1002/gin2.70055}
}
Kostenlos starten →